Allarity Therapeutics, Inc. Income Taxes Receivable, Current
Allarity Therapeutics, Inc. (ALLR) had Income Taxes Receivable, Current of $1.31 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Nontrade Receivables, Current
us-gaap:IncomeTaxesReceivable · last filed 2026-08-14
- 2026-06-30: Income Taxes Receivable, Current $1.31M.
- 2026-03-31: Income Taxes Receivable, Current $1.08M.
- 2025-12-31: Income Taxes Receivable, Current $866.00K.
- 2025-09-30: Income Taxes Receivable, Current $1.66M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-06-30 | $1.31M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $866.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.66M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.61M 10-Q · filed 2025-08-15 |
| 2025-03-31 | $1.11M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $770.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.65M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.58M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $1.33M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $815.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.56M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $789.00K 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |